<SEC-DOCUMENT>0001654954-18-013611-index.html : 20181206 <SEC-HEADER>0001654954-18-013611.hdr.sgml : 20181206 <ACCEPTANCE-DATETIME>20181206083126 ACCESSION NUMBER: 0001654954-18-013611 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20181206 DATE AS OF CHANGE: 20181206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENAX THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000034956 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 262593535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-228212 FILM NUMBER: 181219023 BUSINESS ADDRESS: STREET 1: ONE COPLEY PARKWAY STREET 2: SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-806-4414 MAIL ADDRESS: STREET 1: ONE COPLEY PARKWAY STREET 2: SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: OXYGEN BIOTHERAPEUTICS, INC. DATE OF NAME CHANGE: 20080703 FORMER COMPANY: FORMER CONFORMED NAME: SYNTHETIC BLOOD INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SINEQUANON CORP DATE OF NAME CHANGE: 19901219 </SEC-HEADER> <DOCUMENT> <TYPE>S-1/A <SEQUENCE>1 <FILENAME>tenx_s1a.htm <DESCRIPTION>REGISTRATION STATEMENT <TEXT> Document 1 - file: tenx_s1a.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>tenx_ex11.htm <DESCRIPTION>UNDERWRITING AGREEMENT <TEXT> Document 2 - file: tenx_ex11.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.2 <SEQUENCE>3 <FILENAME>tenx_ex42.htm <DESCRIPTION>SERIES A PREFERRED STOCK CERTIFICATE <TEXT> Document 3 - file: tenx_ex42.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.5 <SEQUENCE>4 <FILENAME>tenx_ex45.htm <DESCRIPTION>FORM OF WARRANT AGENCY AGREEMENT <TEXT> Document 4 - file: tenx_ex45.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>5 <FILENAME>tenx_ex51.htm <DESCRIPTION>OPINION ON LEGALITY <TEXT> Document 5 - file: tenx_ex51.htm
</DOCUMENT> </SEC-DOCUMENT>